Evidence about the clinical benefits of Hyperbaric Oxygen Therapy (HBOT) in patients with Fournier's Gangrene (FG) is controversial and inconclusive. We aimed to compare the mortality related to FG between patients undergoing surgical debridement and/or standard antibiotic therapy alone or in combination with HBOT.
Hyperbaric Oxygen Therapy reduces mortality in patients with Fournier's gangrene. Results from a multi-institutional observational study / Creta, Massimiliano; Longo, Nicola; Arcaniolo, Davide; Giannella, Riccardo; Cai, Tommaso; Cicalese, Annarita; De Nunzio, Cosimo; Grimaldi, Giovanni; Cicalese, Virgilio; De Sio, Marco; Autorino, Riccardo; Lima, Estevao; Fedelini, Paolo; Marmo, Mariano; Capece, Marco; La Rocca, Roberto; Tubaro, Andrea; Imbimbo, Ciro; Mirone, Vincenzo; Fusco, Ferdinando. - In: MINERVA UROLOGICA E NEFROLOGICA. - ISSN 1827-1758. - (2020). [10.23736/S0393-2249.20.03696-6]
Hyperbaric Oxygen Therapy reduces mortality in patients with Fournier's gangrene. Results from a multi-institutional observational study
Creta, Massimiliano;Longo, Nicola;Arcaniolo, Davide;Grimaldi, Giovanni;Capece, Marco;La Rocca, Roberto;Imbimbo, Ciro;Mirone, Vincenzo;Fusco, Ferdinando
2020
Abstract
Evidence about the clinical benefits of Hyperbaric Oxygen Therapy (HBOT) in patients with Fournier's Gangrene (FG) is controversial and inconclusive. We aimed to compare the mortality related to FG between patients undergoing surgical debridement and/or standard antibiotic therapy alone or in combination with HBOT.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
